Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer; Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05236582
What this trial is testing

Herombopag for Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced ThrombocytopeniaHerombopag
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableStudy completedNCT05433246
What this trial is testing

Effects of Massage Therapy on Peripheral Neuropathy and Quality of Life

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Fatma Arikan 52
Testing effectiveness (Phase 2)WithdrawnNCT01269203
What this trial is testing

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00376961
What this trial is testing

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 68
Early research (Phase 1)Active Not RecruitingNCT04092270
What this trial is testing

A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer

Who this might be right for
Endometrial High Grade Endometrioid AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+26 more
National Cancer Institute (NCI) 55
Post-approval studies (Phase 4)Study completedNCT02081469
What this trial is testing

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

Who this might be right for
Hepatitis B, ChronicTumor
Chang Gung Memorial Hospital 100
Not applicableLooking for participantsNCT06150469
What this trial is testing

Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies

Who this might be right for
Hematological Malignancies
University Hospital, Limoges 286
Not applicableEnded earlyNCT00610818
What this trial is testing

Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Skin Rash
McGill University Health Centre/Research Institute of the McGill University Health Centre 7
Not applicableUnknownNCT03852290
What this trial is testing

C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine Effectiveness in Metastatic Colon Cancer

Who this might be right for
Colon CancerMTHFR Gene MutationChemotherapeutic Toxicity+1 more
Universidad de Costa Rica 65
Not applicableStudy completedNCT03884413
What this trial is testing

FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France

Who this might be right for
Breast Cancer Female
Institut Curie 517
Testing effectiveness (Phase 2)Looking for participantsNCT07483359
What this trial is testing

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma (HCC)Portal Vein Tumor Thrombus
First Hospital of China Medical University 38
Early research (Phase 1)Study completedNCT00020488
What this trial is testing

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00460603
What this trial is testing

Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Pfizer 187
Testing effectiveness (Phase 2)UnknownNCT06375486
What this trial is testing

Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01432223
What this trial is testing

Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab

Who this might be right for
Breast CancerHER-2 Positive Breast CancerEffects of Chemotherapy
Osaka Medical College 46
Testing effectiveness (Phase 2)Looking for participantsNCT07253896
What this trial is testing

Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab

Who this might be right for
Safety
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Testing effectiveness (Phase 2)Ended earlyNCT00061646
What this trial is testing

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Abbott 25
Not applicableStudy completedNCT05213403
What this trial is testing

Innovative "Scoring System" in Breast Cancer Post Neoadiuvant Chemotherapy

Who this might be right for
Early Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 255
Large-scale testing (Phase 3)UnknownNCT02960061
What this trial is testing

Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer

Who this might be right for
Survival
Sixth Affiliated Hospital, Sun Yat-sen University 640
Post-approval studies (Phase 4)Not Yet RecruitingNCT07302841
What this trial is testing

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Tianjin Medical University Cancer Institute and Hospital 28
Next Page